Analysts expect Protalix BioTherapeutics, Inc. to report revenue of 12.77 M for Q3 26, against a range of 12.14 M to 13.40 M. The most recent reported quarter, Q2 26, came in at 19.90 M, a 47.6% beat against the 13.48 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 17.96 M | 18.22 M | 10.11 M | 15.66 M | 17.85 M | 9.12 M | 33.75 M | 19.90 M | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 18.35 M | 18.98 M | 22.21 M | 15.69 M | 20.07 M | 20.36 M | 11.52 M | 14.29 M | 13.40 M | 15.51 M | 14.89 M | 19.36 M | 12.68 M | 15.06 M | 20.81 M | 22.09 M | ||||||
| Low Estimate | 16.03 M | 16.72 M | 19.60 M | 14.60 M | 17.81 M | 17.98 M | 10.84 M | 12.67 M | 12.14 M | 14.60 M | 13.95 M | 17.24 M | 10.40 M | 13.34 M | 19.45 M | 18.60 M | ||||||
| Consensus Estimate | 17.19 M | 17.85 M | 20.91 M | 15.15 M | 18.94 M | 19.17 M | 11.18 M | 13.48 M | 12.77 M | 15.05 M | 14.42 M | 18.30 M | 11.54 M | 14.20 M | 20.13 M | 20.35 M |
Analysts expect Protalix BioTherapeutics, Inc. to report earnings per share of -0.02 for Q3 26, against a range of -0.02 to -0.02. The most recent reported quarter, Q2 26, came in at 0.05, a 600.0% beat against the -0.01 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.03 | 0.10 | -0.05 | 0.00 | 0.03 | -0.06 | 0.22 | 0.05 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 0.07 | 0.07 | 0.08 | 0.04 | 0.06 | 0.04 | -0.01 | -0.01 | -0.02 | -0.01 | 0.01 | 0.01 | -0.04 | -0.05 | 0.04 | 0.02 | ||||||
| Low Estimate | 0.05 | 0.07 | 0.08 | 0.04 | 0.06 | 0.04 | -0.01 | -0.01 | -0.02 | -0.01 | 0.01 | 0.01 | -0.04 | -0.05 | 0.04 | 0.02 | ||||||
| Consensus Estimate | 0.06 | 0.07 | 0.08 | 0.04 | 0.06 | 0.04 | -0.01 | -0.01 | -0.02 | -0.01 | 0.01 | 0.01 | -0.04 | -0.05 | 0.04 | 0.02 |
Pull Wall Street consensus for Protalix BioTherapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PLX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PLX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PLX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();